Age, yrs, mean (SD) | 60.7 (9.1) | 60.7 (7.3) | 0.553* |
Disease onset, yrs, mean (SD) | 4.7 (4.2) | 5.2 (3.0) | 0.151* |
Female/male | 30 (100)/0 | 28 (93.3)/2 (6.7) | 0.15** |
White/non-white | 17 (56.7)/13 (43.3) | 25 (83.3)/5 (16.7) | 0.034** |
KL grade in the injected joint | | | 0.180** |
I | 4 (13.3) | 5 (16.7) | |
II | 7 (23.3) | 4 (13.3) | |
III | 8 (26.7) | 3 (10) | |
IV | 11 (36.7) | 18 (60) | |
Radiograph erosion, whole hand | | | 0.297** |
No erosion | 19 (63.3) | 15 (50) | |
Erosion | 11 (36.7) | 15 (50) | |
Drugs | | | 0.423** |
No drugs | 23 (76.7) | 18 (60) | |
Hydroxychloroquine | 1 (3.3) | 2 (6.7) | |
Glucosamine sulfate | 5 (16.7) | 5 (16.7) | |
Glucosamine sulfate + chondroitin sulfate | 0 | 3 (10) | |
Methotrexate | 1 (3.3) | 1 (3.3) | |
NSAID, sodium diclofenac, mg/day (SD) | 3.3 (18.2) | 1.7 (9.1) | 0.981* |
Paracetamol, 750 mg, tablets/day (SD) | 0.6 (1.1) | 0.2 (0.4) | 0.127* |
IP joint studied | | | |
DIP | 14 (46.7) | 15 (50) | 0.796** |
PIP | 16 (53.3) | 15 (50) | 0.423** |